Clinical usefulness of noninvasive fibrosis indices for predicting hepatocellular carcinoma in treatment-naïve patients with chronic hepatitis B following entecavir therapy.

Jeong, Joonho; Shin, Jung Woo; Jung, Seok Won; Lee, Seung Bum; Park, Eun Ji; Park, Neung Hwa

Jeong, Joonho; Shin, Jung Woo; Jung, Seok Won; Lee, Seung Bum; Park, Eun Ji; Park, Neung Hwa.

Afiliação

Jeong J; Department of Internal Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea.
Shin JW; Department of Internal Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea.
Jung SW; Department of Internal Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea.
Lee SB; Department of Internal Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea.
Park EJ; Biomedical Research Center, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea.
Park NH; Department of Internal Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea.

Hepatol Res ; 51(9): 923-932, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34224182

Palavras-chave

APRI; FIB-4; chronic hepatitis B; entecavir; hepatocellular carcinoma; modified FIB-4

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google